Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests
- PMID: 10642232
- PMCID: PMC27270
- DOI: 10.1136/bmj.320.7229.220
Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests
Abstract
Objectives: To assess the probability of left ventricular systolic dysfunction without echocardiography in patients from general practice.
Design: Cross sectional study using multivariate regression models to examine the relation between clinical variables and left ventricular systolic dysfunction as determined by echocardiography.
Setting: Three general practices in Copenhagen.
Subjects: 2158 patients aged >40 years were screened by questionnaires and case record reviews; 357 patients with past or present signs or symptoms of heart disease were identified, of whom 126 were eligible for and consented to examination.
Main outcome measures: Clinical variables that were significantly (P<0.05) related to ejection fraction </=0.45 and their predictive value for left ventricular systolic dysfunction.
Results: 15 patients (12%) had left ventricular systolic dysfunction. The prevalence was significantly related to three questions: does the electrocardiogram have Q waves, left bundle branch block, or ST-T segment changes? (P=0.012); is resting supine heart rate greater than the simultaneous diastolic blood pressure? (P=0.002); and is plasma N-terminal atrial natriuretic peptide>0.8 nmol/l? (P=0.040)? Only one of 60 patients with a normal electrocardiogram had systolic dysfunction (2%, 95% confidence interval 0% to 9%) regardless of response to the other two questions. The risk of dysfunction was appreciable in patients with a yes answer to two or three questions (50%, 27% to 73%).
Conclusions: A normal electrocardiogram implies a low risk of left ventricular systolic dysfunction. Patients can be identified for echocardiography on the basis of an abnormal electrocardiogram combined with increased natriuretic peptide concentration or a heart rate greater than diastolic blood pressure, or both.
Comment in
- 
  
  Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factor.BMJ. 2000 Jul 8;321(7253):111-2. BMJ. 2000. PMID: 10950527 Free PMC article. No abstract available.
- 
  
  Predicting left ventricular systolic dysfunction. Combining test results gives best predictive effect.BMJ. 2000 Oct 7;321(7265):895; author reply 895-6. BMJ. 2000. PMID: 11021881 Free PMC article. No abstract available.
References
- 
    - Bristow MR, Gilbert EM, Abraham WT, Adams KP, Fowler MB, Hershberger RE, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure (MOCHA investigators) Circulation. 1996;94:2807–2816. - PubMed
 
- 
    - SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691. - PubMed
 
- 
    - CIBIS-II Investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13. - PubMed
 
- 
    - SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302. - PubMed
 
- 
    - Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992;327:669–677. - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Miscellaneous
 
        